Lakefront Biotherapeutics | GLPG - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
argenx SE 33.43 2.1 2026-09
AstraZeneca 24.63 0.71 2026-09
Biogen 29.15 5.92 2026-09
Genmab 16.04 1.05 2026-06
Gilead Sciences 17.68 4.18 2026-09
GlaxoSmithKline 9.72 0.9 2026-09
GRIFOLS 13.04 1.66 2026-09
Hikma Pharmaceutical 10.43 3.72 2025-12
Incyte 54.54 40.08 2026-09
Merck 17.21 4.47 2026-06
Neurocrine Biosciences 83.17 61.07 2026-09
Novartis 19.17 3.24 2026-09
Roche Holding 16.48 0.39 2026-06
Sanofi 22.34 3.38 2026-09
UCB 29.7 5.52 2025-12
Vertex Pharmaceuticals 29.35 1.3 2026-09